Tenon Medical, Inc.
Tenon Medical, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||||
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 2 | 5 | 4 | 3 | 8 | 10 | 7 | 9 | 2 | 4 | 2 | 3 | |||||
Accounts Receivable Net Current | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Inventory Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | |||||
Prepaid Expense Current | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | - | 0 | - | |||||
Assets Current | 5 | 8 | 7 | 7 | 10 | 12 | 8 | 11 | 4 | 6 | 4 | 5 | |||||
Property Plant And Equipment Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Deposits Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | |||||
Deferred Costs | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |||||
Intangible Assets Net Excluding Goodwill | 0 | 0 | 0 | 1 | - | - | - | - | - | - | - | - | |||||
Goodwill | 2 | 2 | 2 | 2 | - | - | - | - | - | - | - | - | |||||
Assets | 10 | 13 | 11 | 10 | 11 | 13 | 10 | 13 | 6 | 8 | 6 | 7 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | |||||
Accrued Liabilities Current | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Accrued Sales Commission Current | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | - | - | 0 | - | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Convertible Notes Payable Current | 4 | 3 | - | - | - | - | - | - | - | - | 1 | - | |||||
Derivative Liabilities Current | 0 | 1 | - | - | - | - | - | - | - | - | - | - | |||||
Liabilities Current | 8 | 7 | 3 | 3 | 3 | 2 | 2 | 3 | 3 | 2 | 3 | 3 | |||||
Operating Lease Liability Noncurrent | 1 | 1 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Asset Acquisition Contingent Consideration Liabili… | 1 | 1 | 1 | 1 | - | - | - | - | - | - | - | - | |||||
Liabilities | 12 | 11 | 6 | 6 | 4 | 4 | 4 | 5 | 5 | 4 | 6 | 5 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 84 | 84 | 83 | 80 | 78 | 78 | 71 | 70 | 60 | 59 | 56 | 55 | |||||
Retained Earnings Accumulated Deficit | -89 | -85 | -81 | -78 | -75 | -72 | -69 | -66 | -62 | -59 | -55 | -52 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | - | - | - | - | - | - | - | - | - | - | -0 | -0 | |||||
Stockholders Equity | -2 | 2 | 5 | 5 | 7 | 9 | 6 | 8 | 1 | 4 | 1 | 3 | |||||
Liabilities And Stockholders Equity | 10 | 13 | 11 | 10 | 11 | 13 | 10 | 13 | 6 | 8 | 6 | 7 | |||||
Debt Instrument Unamortized Discount Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | |||||
Series A Preferred Stock | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Series B Preferred Stock | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | - | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 1 | 0 | 0.001 | 0.001 | 0.001 | 0 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 130 | 130 | 130 | 130 | 130 | 130 | 130 | 130 | 130 | 130 | 130 | 130 | |||||
Shares Outstanding | 0 | 11 | 11 | 9 | 8 | 8 | 3 | 3 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Issued | 0 | 11 | 11 | 9 | 8 | 8 | 3 | 3 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -14.57% | -58.70% | -71.99% | - | - | - | - | - | - | - | - | - |
| 2025 | -19.35% | -20.48% | 17.74% | -29.34% | -26.35% | -28.14% | -5.93% | -17.46% | -24.92% | 14.57% | 1.00% | -11.86% |
| 2024 | -26.44% | -14.37% | -35.17% | -16.24% | -9.40% | -19.87% | -22.42% | -22.42% | -42.35% | -53.72% | -54.13% | -63.64% |
| 2023 | - | - | - | - | - | - | -49.04% | -49.04% | -63.06% | - | - | - |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.58 | 1.03 | 2.11 | 2.15 | 3.86 | 5.46 | 4.39 | 3.52 | 1.20 | 2.63 | 1.24 | 1.61 | |||||
| Quick Ratio | 0.44 | 0.89 | 1.70 | 1.56 | 3.36 | 5.10 | 3.96 | 3.16 | 0.78 | 2.19 | 0.94 | 1.34 | |||||
| Working Capital | -3.50M | 215.00K | 3.56M | 3.50M | 7.32M | 9.80M | 6.34M | 8.01M | 684.00K | 3.69M | 749.00K | 1.88M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -6.69 | 5.77 | 1.13 | 1.16 | 0.66 | 0.43 | 0.65 | 0.59 | 6.22 | 1.21 | 7.16 | 1.91 | |||||
| Interest Coverage TTM | -12.54 | -70.43 | - | - | - | - | -404.88 | -269.29 | -252.67 | -260.85 | -748.90 | -205.14 | |||||
| Debt Ratio | 1.18 | 0.85 | 0.53 | 0.54 | 0.40 | 0.30 | 0.39 | 0.37 | 0.86 | 0.55 | 0.88 | 0.66 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.51 | 0.35 | 0.38 | 0.28 | 0.34 | 0.31 | 0.40 | 0.33 | 0.43 | 0.41 | 0.34 | 0.22 | |||||
| Days Sales Outstanding TTM | 93.35 | 113.34 | 118.50 | 123.45 | 89.73 | 80.97 | 76.91 | 90.78 | 69.28 | 50.37 | 46.50 | 69.82 | |||||
| Receivables Turnover TTM | 3.91 | 3.22 | 3.08 | 2.96 | 4.07 | 4.51 | 4.75 | 4.02 | 5.27 | 7.25 | 7.85 | 5.23 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -41,759.15 | -1,101.88 | -1,700.43 | -1,552.85 | -58,322.58 | -3,812.34 | -11,262.77 | -15,644.24 | -29,569.30 | -40,131.65 | -68,638.77 | -71,410.53 | |||||
| Free Cash Flow Per Share TTM | -36,451.22 | -1,044.82 | -1,522.21 | -1,086.42 | -34,447.00 | -2,825.69 | -8,350.91 | -11,053.59 | -22,296.38 | -31,767.51 | -55,259.91 | -49,684.21 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 66.81% | 64.82% | 59.79% | 52.40% | 45.44% | 47.62% | 52.21% | 57.83% | 60.32% | 54.70% | 42.38% | 19.82% | |||||
| Operating Profit Margin TTM | -242.70% | -269.63% | -324.34% | -405.17% | -438.48% | -424.39% | -420.08% | -414.30% | -412.13% | -446.39% | -537.12% | -855.82% | |||||
| Net Profit Margin TTM | -257.85% | -270.09% | -318.36% | -396.26% | -429.45% | -417.57% | -417.24% | -413.88% | -411.27% | -445.77% | -532.14% | -849.06% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 80.25% | 39.98% | 20.35% | -2.47% | -12.60% | 2.18% | 11.92% | 38.30% | 103.01% | 205.22% | 323.73% | - | |||||
| Net Income Growth (1Y) | 8.23% | -9.46% | -8.17% | -6.63% | -8.74% | -4.29% | -12.25% | -32.59% | -31.32% | -33.03% | -17.63% | - | |||||
| EPS Growth (1Y) | -28.40% | -71.10% | -84.90% | -90.07% | 97.24% | -90.50% | -83.59% | -78.09% | -76.11% | -73.64% | -63.68% | - | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |||||
| P/B TTM | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| P/S TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Market Cap | 106.93 | 8.18K | 7.03K | 9.73K | 212.01 | 7.59K | 2.28K | 3.72K | 2.29K | 2.71K | 2.87K | 3.53K | |||||
| Enterprise Value | 2.66M | -1.12M | -3.75M | -3.43M | -7.85M | -10.30M | -6.53M | -9.16M | -1.97M | -4.39M | -1.25M | -3.37M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -11.96M | -11.77M | -11.24M | -8.96M | -7.48M | -10.16M | -10.14M | -9.69M | -10.46M | -11.34M | -12.54M | -14.16M | |||||
| Net Debt | 2.66M | -1.13M | -3.76M | -3.44M | -7.85M | -10.31M | -6.54M | -9.16M | -1.97M | -4.39M | -1.26M | -3.37M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Tenon Medical, Inc. (TNON) — SEC Financial Statements & Analysis
Tenon Medical, Inc. (TNON) is a surgical & medical instruments & apparatus company, incorporated in DE. Tenon Medical, Inc. trades on Nasdaq as: TNON, TNONW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Tenon Medical, Inc. reported a 80.25% year-over-year revenue growth, a Gross Profit Margin of 66.81% (TTM), a Debt-to-Equity ratio of -6.69x, a Price-to-Sales (P/S) ratio of 0.00x (TTM), a Price-to-Book (P/B) ratio of -0.00x (TTM), at a market cap of $106.93. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 80.25%
- Gross Profit Margin TTM
- 66.81%
- Debt To Equity
- -6.69x
- P/S TTM
- 0.00x
- P/B TTM
- -0.00x
- Market Cap
- $106.93
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Tenon Medical, Inc. in?
Tenon Medical, Inc. (TNON) operates in the Surgical & Medical Instruments & Apparatus industry.
What is TNON's market cap?
Tenon Medical, Inc. (TNON) has a market capitalization of $106.93 as of 2026-06-30.
What exchange does TNON trade on?
Tenon Medical, Inc. (TNON) trades on the Nasdaq.
Where is Tenon Medical, Inc. incorporated?
Tenon Medical, Inc. is incorporated in DE.